로딩 중…
StockDiggingStockDigging

PharmaResearch

214450· KOSDAQ
₩294,000-1.34%
2026-06-19

Price Chart

PharmaResearch-34.96%

Financials

Investment Metrics(as of 2026-06-19)

MetricValue
Size
Market Cap3.05T KRW
Revenue565.48B KRW
Net Income180.98B KRW
Total Assets1.09T KRW
Net Assets732.48B KRW
Employees436
Value
P/E16.88x
P/B4.17x
PEG0.48x
P/S5.40x
EV/EBITDA44.30x
FCF Yield5.02%
Profitability
ROE24.71%
ROA16.67%
Op. Margin40.13%
Revenue Growth24.97%
Earnings Growth35.31%
Financial Health
Debt Ratio148.18%
Total Debt6.25B KRW
FCF153.44B KRW
Cash204.37B KRW
Current Ratio5.69x
Net Debt/EBITDA-3.07x
Dividend
Div. Yield1.24%
Div. Growth236.36%
Performance
1Y Return-34.96%
1M Return-0.34%
From 52W High-58.77%
1Y MDD-63.57%
Trading
Volume79,980 shares
Foreign Own.7.29%
Per Share
EPS15,228 KRW
BPS60,258 KRW

Company Info

CEO 손지훈
Employees 436
Founded 2001
HQ 강원도 강릉시, KR

PharmaResearch was founded in 2001 as a pharmaceutical and medical device development and consulting company, later establishing a GMP-certified factory in 2013 and completing its second factory in 2019. As a biopharmaceutical company, it researches, manufactures, and sells pharmaceuticals, medical devices, and cosmetics for various medical fields, including dermatology and orthopedics. Leveraging its technological competitiveness, the company is committed to R&D and market expansion, pursuing global business by entering Asian, European, and North American markets. PharmaResearch was established in 2001 and is headquartered in Gangneung-si, Gangwon-do.